Clinical Trials Directory

Trials / Completed

CompletedNCT07292467

Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 Weeks

Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 Weeks With 1 Application Per Week (Maintenance Phase) on Subjects With Moderate to Severe Dandruff and Severe Itching State.

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Vichy Laboratoires · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study to evaluate the efficacy of shampoo after 4 weeks (treatment phase) and after 5 weeks, 8 weeks, 10 weeks, 12 weeks, 16 weeks, 20 weeks and 24 weeks with 1 application per week (maintenance phase) on subjects with moderate to severe dandruff and severe itching state. Participants will: Apply investigationnal products 3 time a week during 4 weeks and investigational product once a week and neutral product twice a week during 24 weeks Visit the center 10 times during the study for evaluations Keep a diary of their discomfort and the number of times they use the investigational products

Detailed description

=\> after 4 weeks (treatment phase) and 5 weeks, 8 weeks, 10 weeks, 12 weeks, 16 weeks, 20 weeks and 24 weeks with 1 application per week (maintenance phase) Primary objective : • To evaluate the reduction of total dandruff ( adherent and non-adherent) Secondary objectives: * To evaluate the Quality of Life (QoL) evolution * To evaluate the reduction of discomfort (itching, stinging, burning sensation) * To evaluate the reduction of scales * To assess the cosmetic properties of investigational product * To assess the tolerance of investigational product

Conditions

Interventions

TypeNameDescription
OTHERSelenium disulfide1% SeS2

Timeline

Start date
2025-03-19
Primary completion
2025-11-15
Completion
2026-01-30
First posted
2025-12-18
Last updated
2026-03-04

Locations

1 site across 1 country: Mauritius

Source: ClinicalTrials.gov record NCT07292467. Inclusion in this directory is not an endorsement.